These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
348 related items for PubMed ID: 3935025
1. ADA and PNP deficiencies: how it all began. Giblett ER. Ann N Y Acad Sci; 1985; 451():1-8. PubMed ID: 3935025 [No Abstract] [Full Text] [Related]
8. [Congenital immunodeficiency syndrome with adenosine deaminase and purine nucleoside phosphorylase deficiencies (1)]. Sakura N, Usui T, Ito K. Nihon Rinsho; 1977 Jul 10; 35(7):2397-403. PubMed ID: 411963 [No Abstract] [Full Text] [Related]
9. [Congenital immunodeficiency with adenosine deaminase and purine nucleoside phosphorylase deficiency]. Sakura N, Usui T, Ito K. Nihon Rinsho; 1977 Aug 10; 35(8):2564-80. PubMed ID: 411964 [No Abstract] [Full Text] [Related]
10. Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents. Carson DA, Kaye J. Ciba Found Symp; 1978 Aug 10; (68):115-33. PubMed ID: 115660 [Abstract] [Full Text] [Related]
11. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase and their implications for therapy of leukemias. Hirschhorn R, Ratech H. Curr Top Hematol; 1983 Aug 10; 4():1-35. PubMed ID: 6413135 [No Abstract] [Full Text] [Related]
12. Therapy in adenosine deaminase and purine nucleoside phosphorylase deficient patients. Zegers BJ, Stoop JW. Clin Biochem; 1983 Feb 10; 16(1):43-7. PubMed ID: 6407780 [Abstract] [Full Text] [Related]
13. Enzyme defects in purine metabolism and immunodeficiencies. Ito K. Nihon Ketsueki Gakkai Zasshi; 1985 Dec 10; 48(8):1764-71. PubMed ID: 3939170 [No Abstract] [Full Text] [Related]
14. Adenosine deaminase and purine nucleoside phosphorylase deficiency: how they were discovered and what they may mean. Giblett ER. Ciba Found Symp; 1978 Dec 10; (68):3-18. PubMed ID: 115664 [No Abstract] [Full Text] [Related]
15. Purinogenic immunodeficiency diseases: clinical features and molecular mechanisms. Mitchell BS, Kelley WN. Ann Intern Med; 1980 Jun 10; 92(6):826-31. PubMed ID: 6247948 [Abstract] [Full Text] [Related]
16. High risk screening of adenosine deaminase and purine nucleoside phosphorylase deficiency in Japan. Kishi T, Sakura N, Ito K, Usui T. Acta Paediatr Jpn; 1987 Feb 10; 29(1):152-4. PubMed ID: 3144840 [No Abstract] [Full Text] [Related]
17. Nucleotide metabolism in cultured T cells and in cells of patients deficient in adenosine deaminase and purine nucleoside phosphorylase. Cohen A, Gudas LJ, Ullman B, Martin DW. Ciba Found Symp; 1978 Feb 10; (68):101-14. PubMed ID: 115659 [No Abstract] [Full Text] [Related]
18. Screening for primary immunodeficiencies associated with purine nucleoside phosphorylase deficiency or adenosine deaminase deficiency. Ito K, Sakura N, Usui T, Uchino H. J Lab Clin Med; 1977 Nov 10; 90(5):844-8. PubMed ID: 409794 [Abstract] [Full Text] [Related]
19. Immune cell function and recycling of purines. Giblett ER. N Engl J Med; 1976 Dec 09; 295(24):1375-6. PubMed ID: 824556 [No Abstract] [Full Text] [Related]